Susceptibility testing of Stenotrophomonas maltophilia to carbapenems

14Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

The susceptibility of 20 clinical isolates of Stenotrophomonas maltophilia to the carbapenems imipenem and meropenem was investigated by various methods. S. maltophilia appeared sensitive to meropenem but resistant to imipenem by disc testing in Iso-sensitest agar. Agar dilution MICs were performed using Iso-sensitest agar and with incubation under three sets of atmospheric conditions. MICs of meropenem were considerably lower than those of imipenem; this effect was maximal after incubation in 5% CO2 when the MIC of meropenem was approximately 64 times less than that of imipenem. Induction experiments showed that both carbapenems could induce production of the L1 carbapenemase. However, disc approximation tests showed that imipenem could induced resistance to meropenem. Partially stably derepressed mutants were readily selected in vitro. We conclude that, although S. maltophilia may give large zones of inhibition to meropenem on disc testing, resistant mutants are readily selected and therefore standard sensitivity tests may be poorly predictive of clinical outcome of treatment of S. maltophilia infections with meropenem.

Cite

CITATION STYLE

APA

Howe, R. A., Wilson, M. P., Walsh, T. R., & Millar, M. R. (1997). Susceptibility testing of Stenotrophomonas maltophilia to carbapenems. Journal of Antimicrobial Chemotherapy, 40(1), 13–17. https://doi.org/10.1093/jac/40.1.13

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free